Neuroprotective Mechanisms Mediated by CDK5 Inhibition

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|5|527-534

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.5, 2016-02, pp. : 527-534

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil

By  

Current Cancer Drug Targets, Vol. 15, Iss. 3, 2015-05 ,pp. : 196-204

Bentham Science Publishers

Access to resources Recommend Favorite

Minocycline: Neuroprotective Mechanisms in Parkinson's Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 6, 2004-02 ,pp. : 679-686

Bentham Science Publishers

Access to resources Recommend Favorite

Cdk5 in the Adult Non-Demented Brain

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 6, 2003-12 ,pp. : 375-381

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's Disease-Associated Neurotoxic Mechanisms and Neuroprotective Strategies

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 4, 2005-08 ,pp. : 383-403

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropharmacological Mechanisms Underlying the Neuroprotective Effects of Methylphenidate

By  

Current Neuropharmacology, Vol. 6, Iss. 4, 2008-12 ,pp. : 379-385

Bentham Science Publishers

Access to resources Recommend Favorite